Alerion is a company specializing in gene therapy. It develops a gene therapy vector platform for the treatment of severe inherited and acquired diseases. The alpharetroviral SIN vectors integrate in a near-random fashion into host cells, avoiding potentially harmful regions, such as promoter or enhancer regions and gene structures.